Skip to content

screening for coronary disease after mediastinal irradiation in Hodgkin Lymphoma survivors

screening for coronary disease after mediastinal irradiation in Hodgkin Lymphoma survivors - SCAR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34730
Enrollment
50
Registered
2010-11-24
Start date
2011-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radiation induced coronary artery disease

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -at least 10 year disease free survival after mediastinal irradiation for Hodgkin lymphoma -current age 40 - 60 yr

Exclusion criteria

Exclusion criteria: - current angina pectoris - current treatment for cardiovascular disease (except hypertension, hypercholesterolemia or cardiac murmurs) -known or symptomatic heart failure -known contrast allergy - known renal function impairment -presence of life threatening disease

Design outcomes

Primary

MeasureTime frame
see objectives

Secondary

MeasureTime frame
see objectives

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)